Published in Lab Business Week, February 20th, 2005
Adjusted net income was $749 million in the fourth quarter of 2004 versus $615 million in 2003, a 22% increase. Full year 2004 adjusted earnings per share were $2.40 versus $1.90 in 2003, a 26% increase. Full year 2004 adjusted net income was $3.1 billion versus $2.5 billion in 2003, a 24% increase.
For 2005, the company expects total revenue growth to be in the high single-digits to low teens range. Adjusted earnings per share are expected to be in the range of $2.70 to $2.85....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.